Spyre Therapeutics Inc (SYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -208,018 | -338,790 | -83,815 | -65,801 | -80,893 |
| Depreciation Amortization | -11,404 | -1,354 | 1,637 | 2,549 | 1,069 |
| Accounts receivable | N/A | 375 | 440 | -815 | N/A |
| Accounts payable and accrued liabilities | -230 | 218 | -2,641 | 1,065 | -544 |
| Other Working Capital | -4,534 | -5,206 | -5,503 | 1,833 | -2,540 |
| Other Operating Activity | 66,776 | 244,847 | 9,738 | 7,453 | 7,133 |
| Operating Cash Flow | $-157,410 | $-99,910 | $-80,144 | $-53,716 | $-75,775 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -353,285 | -126,903 | 57,046 | -22,046 | -3,324 |
| PPE Investments | N/A | 475 | -38 | -573 | -4,280 |
| Net Acquisitions | N/A | 3,035 | N/A | N/A | N/A |
| Other Investing Activity | 0 | 15,000 | 0 | 0 | 0 |
| Investing Cash Flow | $-353,285 | $-108,393 | $57,008 | $-22,619 | $-7,604 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -16 | -418 | -510 | -20 |
| Common Stock Issued | 243,893 | 84,960 | 43,096 | 1,903 | 154,532 |
| Other Financing Activity | 167,013 | 276,133 | 0 | 0 | 0 |
| Financing Cash Flow | $410,906 | $361,077 | $42,678 | $1,393 | $154,512 |
| Exchange Rate Effect | -3 | 25 | -106 | -15 | 51 |
| Beginning Cash Position | 189,215 | 36,416 | 16,980 | 91,937 | 20,753 |
| End Cash Position | 89,423 | 189,215 | 36,416 | 16,980 | 91,937 |
| Net Cash Flow | $-99,792 | $152,799 | $19,436 | $-74,957 | $71,184 |
| Free Cash Flow | |||||
| Operating Cash Flow | -157,410 | -99,910 | -80,144 | -53,716 | -75,775 |
| Capital Expenditure | N/A | N/A | -38 | -573 | -4,280 |
| Free Cash Flow | -157,410 | -99,910 | -80,182 | -54,289 | -80,055 |